Trial Profile
Genetic-determinants of Protease Inhibitor Pharmacology
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 08 Jul 2011 New trial record